表紙
市場調査レポート

欧州の癌診断検査市場における機会

Tumor Markers: France, Germany, Italy, Spain, UK--Market Analysis, Competitive Intelligence, Technology Trends, Opportunities for Suppliers

発行 Venture Planning Group 商品コード 282127
出版日 ページ情報 英文 820 Pages
納期: 即日から翌営業日
価格
本日の銀行送金レート: 1USD=106.71円で換算しております。

Local License: 同一事業所内

Back to Top
欧州の癌診断検査市場における機会 Tumor Markers: France, Germany, Italy, Spain, UK--Market Analysis, Competitive Intelligence, Technology Trends, Opportunities for Suppliers
出版日: ページ情報: 英文 820 Pages
概要

当レポートでは、欧州の癌診断検査市場における今後5年間のビジネス機会について調査分析し、主要国(フランス、ドイツ、イタリア、スペイン、英国)の主要動向を検証するほか、現在/新興の診断検査、様々な診断技術の潜在的用途、主な腫瘍マーカーの売上予測(国別、市場セグメント別)、主要企業のプロファイル、主要サプライヤーの戦略的プロファイルなどを提供して、概略以下の構成でお届けいたします。

第1章 イントロダクション

第2章 主な製品開発の機会

  • 試薬キットと検査システム/パネル
  • 機器
  • コンピューター、ソフトウェア、オートメーション
  • 補助製品

第3章 分散型検査製品の設計基準

第4章 代替的な市場浸透戦略

  • 内部開発
  • 共同事業協定
  • 大学との契約
  • 流通戦略

第5章 潜在的な市場参入障壁とリスク

  • 市場の成熟度
  • 費用抑制
  • 競合
  • 技術面での優位性と限界
  • 特許権保護
  • 規制上の制約
  • 分散型検査市場の課題

第6章 世界の市場と技術の概要

  • 癌の統計と病因
    • 乳癌
    • 肺癌
    • 結腸・直腸癌
    • 前立腺癌
    • 胃癌
    • 白血病
    • リンパ腫
    • 口腔癌
    • 皮膚癌
    • 子宮癌
    • 卵巣癌
    • 膀胱癌
  • 現在/新興の癌診断検査
    • イントロダクション
    • 腫瘍マーカーの分類
    • ACTH
    • アルファフェトプロテイン(AFP)
    • β2ミクログロブリン
    • CA 15-3/27.29
    • CA 19-9
    • CA-125
    • カルシトニン
    • 癌胎児性抗原(CEA)
    • エストロゲン・プロゲステロン受容体
    • フェリチン
    • ガストリン
    • ヒト絨毛性ゴナドトロピン(HCG)
    • インスリン
    • NSE
    • 潜血
    • パップスメア/HPV
    • 前立腺酸性フォスファターゼ(PAP)
    • 前立腺特異抗原(PSA)
    • 扁平上皮癌関連抗原(SCC)
    • T・Bリンパ球
    • TdT
    • サイログロブリン
    • 組織ポリペプチド抗原(TPA)
    • 生化学腫瘍マーカー
    • 腫瘍遺伝子
    • ポリペプチド増殖因子
    • 異所性ホルモン
    • コロニー刺激因子
    • リンフォカイン
    • 免疫組織化学染色
    • 新興の腫瘍マーカー
  • 診断装置のレビューと市場ニーズ
  • 現在/新興の技術
    • モノクローナル/ポリクローナル抗体
    • 免疫測定法
    • 分子診断
    • 染色体分析
    • 人工知能
    • フローサイトメトリー
    • 二次元ゲル電気泳動(2-DGE)
    • バイオセンサー
    • 競合/補完技術
  • 個人向け検査

第7章 フランス

  • エグゼクティブサマリー
  • ビジネス環境
  • 市場構造
  • 市場規模、成長率、主要サプライヤーの売上高と市場シェア

第8章 ドイツ

  • エグゼクティブサマリー
  • ビジネス環境
  • 市場構造
  • 市場規模、成長率、主要サプライヤーの売上高と市場シェア

第9章 イタリア

  • エグゼクティブサマリー
  • ビジネス環境
  • 市場構造
  • 市場規模、成長率、主要サプライヤーの売上高と市場シェア

第10章 スペイン

  • エグゼクティブサマリー
  • ビジネス環境
  • 市場構造
  • 市場規模、成長率、主要サプライヤーの売上高と市場シェア

第11章 英国

  • エグゼクティブサマリー
  • ビジネス環境
  • 市場構造
  • 市場規模、成長率、主要サプライヤーの売上高と市場シェア

第12章 競合企業プロファイル

  • Abbott
  • AdnaGen
  • Applied Gene Technologies
  • Beckman Coulter/Danaher
  • Becton Dickinson
  • Biomedical Diagnostics
  • bioMerieux
  • Bio-Rad
  • CellSearch
  • Cepheid
  • Dako
  • Decode
  • Diadexus
  • Diagnocure
  • Diasorin
  • 栄研化学
  • Enterix
  • Enzo Biochem
  • Epigenomics
  • Exact Sciences
  • 富士レビオ
  • Gen-Probe
  • Guided Therapeutics
  • Hologic
  • Kreatech
  • 協和メデックス
  • Life Technologies
  • Mackay Life Sciences
  • Myriad Genetics
  • Nanogen Elitech
  • Nuvelo
  • OncoLab
  • Ortho-Clinical Diagnostics
  • Panacea Pharmaceuticals
  • Polartechnics
  • Polymedco
  • PreMD
  • Qiagen/Ipsogen
  • Radient Pharmaceuticals
  • Roche
  • Scienion
  • Sequenom
  • Siemens Healthcare
  • タカラバイオ
  • Targeted Diagnostics & Therapeutics
  • 東ソー
  • Vermillion/Correlogic Systems
  • 和光純薬工業
  • Wallac/PE
  • Zila

第13章 付録

図表

このページに掲載されている内容は最新版と異なる場合があります。詳細はお問い合わせください。

目次
Product Code: VPTM18962

Summary

This comprehensive five-country report contains 820 pages, 320 tables, and presents analysis of the major business opportunities emerging in the cancer diagnostics market during the next five years. The report examines trends in major European countries (France, Germany, Italy, Spain, UK); reviews current and emerging tests; analyzes potential applications of various diagnostic technologies; forecasts sales of major tumor markers by country and market segment; profiles leading market players and potential entrants; and suggests alternative business expansion strategies for suppliers.

Rationale

The cancer diagnostics market is on the verge of explosion, as the researchers approach major technological breakthroughs in tumor diagnosis and therapy, discover new specific antigens, and unlock the mystery of the genetic basis of the disease. During the next five years, the European cancer diagnostics market is promising to be an exciting, dynamic and rapidly expanding field. Anticipated technological breakthroughs will create numerous opportunities for determining genetic predisposition, detecting specific tumors, and monitoring biological response to cancer therapy. The rise in geriatric population will further compound the growing demand for malignancy assays and the rapid market expansion.

Cancer Diagnostic Tests

ACTH, AFP, Beta-2 Microglobulin, CA 15-3/27.29, CA 19-9, CA 125, Calcitonin, Cathepsin, CEA, Chromogranin, Colon-Specific Antigen, Cytokeratins, Estrogen Receptor, Ferritin, Gastrin, HCG, Insulin, Interferons, Interleukins, Lymphocyte Subtyping, Neuron-Specific Enolase, Nucleolar, Occult Blood, Oncogenes, Pancreatic Oncofetal Antigen, Pap Smear, Parathyroid Hormone, Progesterone Receptor, Prostatic Acid Phosphatase, Prostatic Specific Antigen, S-100 Protein, Serotonin, Sialic Acid, Squamous Cell Carcinoma Ag, TDT, Thymidine Kinase, Thyroglobulin, Tissue Polypeptide Antigen, and others.

Geographic Coverage

France, Germany, Italy, Spain, UK

Market Segmentation Analysis

- Sales and market shares of major suppliers, by individual cancer diagnostic test and country.

- Five-year test volume and sales forecasts for major cancer diagnostic tests by country and market segment, including:

- Hospitals Commercial/Private Laboratories Physician Offices/Group Practices

- Comprehensive market segmentation analysis, including review of the market dynamics, structure, size, growth and major suppliers by country.

- Cancer statistics, etiology and recent developments in five major European countries.

Current and Emerging Products

- Review of over 200 current and emerging cancer diagnostic tests, including:

- Biochemical Markers Oncogenes Growth Factors Hormones Colony Stimulating Factors Lymphokines Immunohistochemical Stains, and others.

- Analysis of major immunoassay analyzers used for cancer diagnostic testing, including their operating characteristics, features and selling prices.

Technology Review

- Assessment of monoclonal antibodies, immunoassays, DNA probes, biochips/microarrays, chromosome analysis, IT, artificial intelligence, flow cytometry, biosensors, and other technologies and their potential applications for cancer diagnostic testing.

- Review of competing/complementing technologies, including CT, MRI, NMR, PET and photonics spectroscopy.

- Extensive listings of over 500 companies, universities and research centers developing new cancer diagnostic tests and detection technologies.

Competitive Assessments

- Strategic assessments of major suppliers and start-up firms developing innovative technologies and products, including their sales, product portfolios, marketing tactics, collaborative arrangements, and new products in R&D.

Business Opportunities and Strategic Recommendations

- Specific new product development opportunities with potentially significant market appeal during the next five years.

- Design criteria for new products.

- Alternative market penetration strategies.

- Potential market entry barriers and risks.

Contains 820 pages and 320 tables

Table of Contents

I. Introduction

II. Worldwide Market Overview

  • 1. Market Overview
  • 2. Worldwide Market Structure
  • 3. Worldwide Market Size and Growth

III. Major Product Development Opportunities

  • A. Reagent Kits and Test Systems/Panels
  • B. Instrumentation
  • C. Computers, Software and Automation
  • D. Auxiliary Products

IV. Design Criteria for Decentralized Testing Products

V. Alternative Market Penetration Strategies

  • A. Internal Development
  • B. Collaborative Arrangements
  • C. University Contracts
  • D. Distribution Strategies

VI. Potential Market Entry Barriers and Risks

  • A. Market Maturity
  • B. Cost Containment
  • C. Competition
  • D. Technological Edge and Limitations
  • E. Patent Protection
  • F. Regulatory Constraints
  • G. Decentralized Testing Market Challenges

VII. Worldwide Market and Technology Overview

  • A. Cancer Statistics and Etiology
    • 1. Breast Cancer
    • 2. Lung Cancer
    • 3. Colon and Rectum Cancer
    • 4. Prostate Cancer
    • 5. Stomach Cancer
    • 6. Leukemia
    • 7. Lymphoma
    • 8. Oral Cancer
    • 9. Skin Cancer
    • 10. Uterine Cancer
    • 11. Ovarian Cancer
    • 12. Bladder Cancer
  • B. Major Current And Emerging Cancer Diagnostic Tests
    • 1. Introduction
    • 2. Tumor Marker Classification
    • 3. ACTH
    • 4. Alpha-Fetoprotein (AFP)
    • 5. Beta-2 Microglobulin
    • 6. CA 15-3/27.29
    • 7. CA 19-9
    • 8. CA-125
    • 9. Calcitonin
    • 10. Carcinoembrionic Antigen (CEA)
    • 11. Estrogen and Progesterone Receptors
    • 12. Ferritin
    • 13. Gastrin
    • 14. Human Chorionic Gonadotropin (HCG)
    • 15. Insulin
    • 16. NSE
    • 17. Occult Blood
    • 18. PAP Smear/HPV
    • 19. Prostatic Acid Phosphatase (PAP)
    • 20. Prostate-Specific Antigen (PSA)
    • 21. Squamous Cell Carcinoma Antigen (SCC)
    • 22. T and B Lymphocytes
    • 23. TdT
    • 24. Thyroglobulin
    • 25. Tissue Polypeptide Antigen (TPA)
    • 26. Biochemical Tumor Markers
    • 27. Oncogenes
      • Abl/abl-bcr
      • AIB1
      • BCL-2
      • BRCA1
      • CD44
      • C-fos
      • C-myb
      • C-myc
      • CYP-17
      • Erb-B
      • HPC1
      • N-myc
      • P40
      • P51
      • P53
      • PIK3CA
      • PTI-1
      • Ras
      • Reg
      • Sis
      • Src
    • 28. Polypeptide Growth Factors
      • Basic Fibroblast Growth Factor
      • Beta-TGF
      • Cachectin (TNT)
      • Calmodulin
      • ECFR
      • Nerve Growth Factor (NGF)
      • Epidermal Growth Factor (EGF)
      • Ornithine Decarboxylase
      • Transferrin
      • Transforming Growth Factor-Alpha
    • 29. Ectopic Hormones
    • 30. Colony Stimulating Factors
    • 31. Lymphokines
      • Alpha-Interferon
      • B Cell Growth Factors
      • B Cell Growth Factor (BCGF)
      • Gamma-Interferon
      • Interleukin-1 (IL-1)
      • Macrophage Activating Factor
    • 32. Immunohistochemical Stains
    • 33. Emerging Tumor Markers
      • N-Acetylglucosamine
      • Actin
      • Alpha-Actin
      • Antineuronal Antibodies
      • 7B2
      • B72.3
      • Bax
      • BCD-F9
      • BLCA-4
      • Blood Group Antigens A,B,H
      • CA 50
      • CA 72-4/TAG-72
      • CA 195
      • CA-242
      • CA-549
      • CAM 26
      • CAR-3
      • Cathepsin-D
      • Chromogranin A and B
      • Cluster 1 Antigen
      • Cluster-5/5A Antigen
      • CTA
      • CU18
      • DR-70
      • DU-PAN-2
      • Endometrial Bleeding Associated Factor
      • Endostatin
      • Epithelial Membrane Antigen
      • Feulgen Hydrolysis
      • Fibronectin
      • FSH
      • (1->3)-L-fucosyltransferase
      • Gastrin-Releasing Peptide (GRP)
      • GDCFP-15
      • Glucagon
      • Glycoamines
      • H23
      • Her-2
      • Human Carcinoma Antigen
      • HPA
      • HSP27
      • Intermediate Filaments
      • Cytokeratins/CK18/Cyfra 21-1
      • Desmin
      • Gliofibrillary Acid Protein
      • Neurofilaments
      • Vimentin
      • KA 93
      • Kinases
      • KP16D3
      • LAI
      • Leukocyte Common Antigen
      • Lewis Antigens
      • Lysophosphatidic Acid (LPA)
      • Ma 695/Ma 552
      • MABDF3
      • MAG
      • ME1
      • Minactivin
      • MN/CA9
      • MSA
      • Mucin Cancer Antigen (MCA)
      • Multiple Tumor Suppressor 1
      • Myosin
      • NEA-130
      • NMP22
      • OA-519
      • Opioid Peptides
      • P-glycoprotein
      • Pancreatic Oncofetal Antigen (POA)
      • Placental Lactogen
      • PR92
      • Proliferative Index, Ki-67
      • Px
      • RB Inactivation/Deletion
      • Ret
      • SCCL 175
      • Selectin
      • Sialic Acid
      • Sialyl SSEA-1/SLX
      • SN10
      • Somatostatin
      • TA-90
      • TABA
      • Tachykinin
      • TAG 12
      • TPS
      • Troponin
      • Tubulin
      • VCAM
      • VEGF
      • Villen
  • C. Cancer Diagnostic Testing Instrumentation Review and Market Needs
  • D. Current and Emerging Cancer Diagnostic Technologies
    • 1. Monoclonal and Polyclonal Antibodies
    • 2. Immunoassays
    • 3. Molecular Diagnostics
    • 4. Chromosome Analysis
      • a. Chronic Myelogenous Leukemia (CML)
      • b. Acute Myeloid Leukemia (AML)
      • c. Acute Lymphoblastic Leukemia (ALL)
      • d. Malignant Lymphomas Lymphoid Malignancies
      • e. Chronic Lymphocytic Leukemia (CLL)
      • f. Solid Cancers
      • g. Chromosomal Translocation and Oncogenes
    • 5. Artificial Intelligence
    • 6. Flow Cytometry
    • 7. Two Dimensional Gel Electrophoresis (2-DGE)
    • 8. Biosensors
    • 9. Competing/Complementing Technologies
  • E. Personal Testing

VIII. France Cancer Diagnostics Market

  • A. Executive Summary
  • B. Business Environment
  • C. Market Structure
  • D. Market Size, Test Volume and Sales Forecasts by Market Segment, Major Supplier Sales and Market Shares by Test

IX. Germany Cancer Diagnostics Market

  • A. Executive Summary
  • B. Business Environment
  • C. Market Structure
  • D. Market Size, Test Volume and Sales Forecasts by Market Segment, Major Supplier Sales and Market Shares by Test

X. Italy Cancer Diagnostics Market

  • A. Executive Summary
  • B. Business Environment
  • C. Market Structure
  • D. Market Size, Test Volume and Sales Forecasts by Market Segment, Major Supplier Sales and Market Shares by Test

XI. Spain Cancer Diagnostics Market

  • A. Executive Summary
  • B. Business Environment
  • C. Market Structure
  • D. Market Size, Test Volume and Sales Forecasts by Market Segment, Major Supplier Sales and Market Shares by Test

XII. U.K. Cancer Diagnostics Market

  • A. Executive Summary
  • B. Business Environment
  • C. Market Structure
  • D. Market Size, Test Volume and Sales Forecasts by Market Segment, Major Supplier Sales and Market Shares by Test

XIII. Competitive Profiles

  • Abbott
  • AdnaGen/Alere
  • Agilent Technologies
  • Applied Gene Technologies
  • Arca Biopharma
  • Beckman Coulter/Danaher
  • Becton Dickinson
  • Biomedical Diagnostics
  • bioMerieux
  • Bio-Rad
  • CellSearch
  • Cepheid
  • Correlogic Systems/Vermillion
  • Decode Genetics
  • Diadexus
  • Diagnocure
  • Diasorin
  • Eiken Chemical
  • Elitech Group
  • Enterix
  • Enzo Biochem
  • Epigenomics
  • Exact Sciences
  • Fujirebio
  • Guided Therapeutics
  • Hologic/Gen-Probe
  • Kreatech/Leica
  • Kyowa Medex
  • Mackay Life Sciences
  • Myriad Genetics
  • OncoLab
  • Ortho-Clinical Diagnostics
  • Panacea Pharmaceuticals
  • Polartechnics
  • Polymedco
  • PreMD
  • Qiagen
  • Quest Diagnostics
  • Radient Pharmaceuticals
  • Roche
  • Scienion
  • Sequenom
  • Siemens Healthcare
  • Takara Bio
  • Targeted Diagnostics & Therapeutics
  • Tosoh
  • Thermo
  • Veridex
  • Wako Pure Chemicals
  • Wallac/PE
  • Zila

XIV. Appendix: Major Universities and Research Centers Developing Cancer Diagnostic Technologies and Applications

List of Tables

  • Tumor Marker Classification
  • Major Companies Developing or Marketing ACTH Tests
  • Major Companies Developing or Marketing AFP Tests
  • Major Companies Developing or Marketing Beta-2 Microglobulin Tests
  • Major Companies Developing or Marketing CA 15-3/27.29 Tests
  • Major Companies Developing or Marketing CA 19-9 Tests
  • Major Companies Developing or Marketing CA 125 Tests
  • Major Companies Developing or Marketing Calcitonin Tests
  • Major Companies Developing or Marketing CEA Tests
  • Major Companies Developing or Marketing Estrogen Receptor Tests
  • Major Companies Developing or Marketing Progesterone Receptor Tests
  • Major Companies Developing or Marketing Ferritin Tests
  • Major Companies Developing or Marketing Gastrin Tests
  • Major Companies Developing or Marketing HCG Tests
  • Major Companies Developing or Marketing Insulin Tests
  • Major Companies Developing or Marketing NSE Tests
  • Major Companies Developing or Marketing Occult Blood Tests
  • Major Companies Developing or Marketing PAP Smear/HPV Tests
  • Major Companies Developing or Marketing PAP Tests
  • Major Companies Developing or Marketing PSA Tests
  • Major Companies Developing or Marketing Lymphocyte Subclassification Tests
  • Biochemical Markers Potential Applications In Cancer Diagnosis
  • Oncogenes Potential Applications In Cancer Diagnosis
  • Major Companies Developing or Marketing Oncogene Tests
  • Growth Factors Potential Applications In Cancer Diagnosis
  • Colony Stimulating Factors Potential Applications in Cancer Diagnosis
  • Lymphokines Potential Applications In Cancer Diagnosis
  • Immunohistochemical Stains Potential Applications in Cancer Diagnosis
  • Executive Summary Table: France, Total Cancer Diagnostic Test Volume and Sales Forecast by Market Segment
  • France, Estimated Cancer Death Rates Per 100,000 Population
  • France, Laboratories Performing Tumor Marker Tests by Market Segment
  • France, Hospital Laboratories Performing Tumor Marker Tests by Bed Size
  • France, Commercial/Private Laboratories Performing Tumor Markers by Annual Test Volume
  • France, Total Tumor Marker Test Volume Forecast by Market Segment
  • France, All Market Segments Major Tumor Marker Test Volume Forecast
  • France, Hospital Laboratories Major Tumor Marker Test Volume Forecast by Test
  • France, Commercial/Private Laboratories Marker Test Volume Forecast
  • France, Total Tumor Marker Sales Major Tumor Forecast by Market Segment
  • France, All Market Segments Major Tumor Marker Sales Forecast by Test
  • France, Hospital Laboratories Major Tumor Marker Sales Forecast by Test
  • France, Commercial/Private Laboratories Cancer Diagnostics Market Forecast by Test
  • France, ACTH Test Volume and Diagnostics Sales Forecast by Market Segment
  • France, AFP Test Volume and Diagnostics Sales Forecast by Market Segment
  • France, Beta-2 Microglobulin Test Volume and Diagnostics Sales Forecast by Market Segment
  • France, CA 15-3/27.29 Test Volume and Diagnostics Sales Forecast by Market Segment
  • France, CA 19-9 Test Volume and Diagnostics Sales Forecast by Market
  • France, CA-125 Test Volume and Diagnostics Sales Forecast by Market Segment
  • France, Calcitonin Test Volume and Diagnostics Sales Forecast by Market Segment
  • France, Cathepsin Test Volume and Diagnostics Sales Forecast by Market Segment
  • France, CEA Test Volume and Diagnostics Sales Forecast by Market Segment
  • France, Colon-Specific Antigen Test Volume And Diagnostics Sales Forecast by Market Segment
  • France, Cytokeratins Test Volume and Diagnostics Sales Forecast by Market Segment
  • France, Estrogen Receptor Test Volume and Diagnostics Sales Forecast by Market Segment
  • France, Ferritin Test Volume and Diagnostics Sales Forecast by Market Segment
  • France, Gastrin Test Volume and Diagnostics Sales Forecast by Market Segment
  • France, HCG Test Volume and Diagnostics Sales Forecast by Market Segment
  • France, Insulin Test Volume and Diagnostics Sales Forecast by Market Segment
  • France, Interferons Test Volume and Diagnostics Sales Forecast by Market Segment
  • France, Interleukins Test Volume and Diagnostics Sales Forecast by Market Segment
  • France, Lymphocyte Subtyping Test Volume And Diagnostics Sales Forecast by Market Segment
  • France, NSE Test Volume and Diagnostics Sales Forecast by Market Segment
  • France, Nucleolar Test Volume and Diagnostics Sales Forecast by Market Segment
  • France, Occult Blood Test Volume and Diagnostics Sales Forecast by Market Segment
  • France, Oncogenes Test Volume and Diagnostics Sales Forecast by Market Segment
  • France, Pancreatic Oncofetal Antigen Test Volume and Diagnostics Sales Forecast by Market Segment
  • France, PAP Smear Test Volume and Diagnostics Sales Forecast by Market Segment
  • France, Parathyroid Hormone Test Volume and Diagnostics Sales Forecast by Market Segment
  • France, Progesterone Receptor Test Volume And Diagnostics Sales Forecast by Market Segment
  • France, PAP Test Volume and Diagnostics Sales Forecast by Market Segment
  • France, PSA Test Volume and Diagnostics Sales Forecast by Market Segment
  • France, S-100 Protein Test Volume and Sales Diagnostics Sales Forecast by Market Segment
  • France, Serotonin Test Volume and Diagnostics Sales Forecast by Market Segment
  • France, Sialic Acid Test Volume and Diagnostics Sales Forecast by Market Segment
  • France, Squamous Cell Carcinoma Antigen Test Volume and Diagnostics Sales Forecast by Market Segment
  • France, TDT Test Volume and Diagnostics Sales Forecast by Market Segment
  • France, Thymidine Kinase Test Volume And Diagnostics Sales Forecast by Market Segment
  • France, Thyroglobulin Test Volume and Diagnostics Sales Forecast by Market Segment
  • France, TPA Test Volume and Diagnostics Sales Forecast by Market Segment
  • France, Total Tumor Marker Sales By Major Suppliers
  • France, AFP Testing Market Diagnostics Sales by Major Supplier
  • France, CA 15-3 Testing Market Diagnostics Sales by Major Supplier
  • France, CA 19-9 Testing Market Diagnostics Sales by Major Supplier
  • France, CA 125 Testing Market Diagnostics Sales by Major Supplier
  • France, CEA Testing Market Diagnostics Sales by Major Supplier
  • France, NSE Testing Market Diagnostics Sales by Major Supplier
  • France, PAP Testing Market Diagnostics Sales by Major Supplier
  • France, PSA Testing Market Diagnostics Sales by Major Supplier
  • Executive Summary Table: Germany, Total Tumor Marker Test Volume and Sales Forecast By Market Segment
  • Germany, Estimated Cancer Death Rates Per 100,000 Population
  • Germany, Laboratories Performing Tumor Marker Tests by Market Segment
  • Germany, Hospital Laboratories Performing Tumor Marker Tests by Bed Size
  • Germany, Commercial/Private Laboratories Performing Tumor Markers by Annual Test Volume
  • Germany, Total Tumor Marker Test Volume Forecast by Market Segment
  • Germany, All Market Segments, Major Tumor Marker Test Volume Forecast
  • Germany, Hospital Laboratories, Major Tumor Marker Test Volume Forecast by Test
  • Germany, Commercial/Private Laboratories Major Tumor Marker Test Volume Forecast
  • Germany, Physician Offices/Group Practices Major Tumor Marker Test Volume Forecast
  • Germany, Total Tumor Marker Sales Forecast by Market Segment
  • Germany, All Market Segments Major Tumor Marker Sales Forecast by Test
  • Germany, Hospital Laboratories, Major Tumor Marker Sales Forecast by Test
  • Germany, Commercial/Private Laboratories Major Tumor Marker Sales Forecast by Test
  • Germany, Physician Offices/Group Practices Major Tumor Marker Sales Forecast by Test
  • Germany, ACTH Test Volume and Diagnostics Sales Forecast by Market Segment
  • Germany, AFP Test Volume and Diagnostics Sales Forecast by Market Segment
  • Germany, Beta-2 Microglobulin Test Volume And Diagnostics Sales Forecast by Market Segment
  • Germany, CA-15-3/27.29 Test Volume and Diagnostics Sales Forecast by Market Segment
  • Germany, CA-19 Test Volume and Diagnostics Sales Forecast by Market Segment
  • Germany, CA 125 Test Volume and Diagnostics Sales Forecast by Market Segment
  • Germany, Calcitonin Test Volume And Diagnostic Sales Forecast by Market Segment
  • Germany, Cathepsin Test Volume and Diagnostics Sales Forecast by Market Segment
  • Germany, CEA Test Volume and Diagnostics Sales Forecast by Market Segment
  • Germany, Chromogranin Test Volume And Diagnostics Sales Forecast by Market Segment
  • Germany, Colon-Specific Antigen Test Volume And Diagnostics Sales Forecast by Market Segment
  • Germany, Cytokeratins Test Volume and Diagnostics Sales Forecast by Market Segment
  • Germany, Estrogen Receptor Test Volume and Diagnostics Sales Forecast by Market Segment
  • Germany, Ferritin Test Volume and Diagnostics Sales Forecast by Market Segment
  • Germany, Gastrin Test Volume and Diagnostics Sales Forecast by Market Segment
  • Germany, HCG, Test Volume and Diagnostics Sales Forecast by Market Segment
  • Germany, Insulin Test Volume and Diagnostics Sales Forecast by Market Segment
  • Germany, Interferons Test Volume and Diagnostics Sales Forecast by Market Segment
  • Germany, Interleukins Test Volume and Diagnostics Sales Forecast by Market Segment
  • Germany, Lymphocyte Subtyping Test Volume and Diagnostics Sales Forecast by Market Segment
  • Germany, NSE Test Volume and Diagnostics Sales Forecast by Market Segment
  • Germany, Occult Blood Test Volume and Diagnostics Sales Forecast by Market Segment
  • Germany, Oncogenes Test Volume and Diagnostics Sales Forecast by Market Segment
  • Germany, Pancreatic Oncofetal Antigen Test Volume and Diagnostics Sales Forecast by Market Segment
  • Germany, Pap Smear Test Volume and Diagnostics Sales Forecast by Market Segment
  • Germany, Parathyroid Hormone Test Volume and Diagnostics Sales Forecast by Market Segment
  • Germany, Progesterone Receptor Test Volume And Diagnostics Sales Forecast by Market Segment
  • Germany, PAP Test Volume and Diagnostics Sales Forecast by Market Segment
  • Germany, PSA Test Volume and Diagnostics Sales Forecast by Market Segment
  • Germany, S-100 Protein Test Volume and Diagnostics Sales Forecast by Market Segment
  • Germany, Serotonin Test Volume and Diagnostics Sales Forecast by Market Segment
  • Germany, Sialic Acid Test Volume and Diagnostics Sales Forecast by Market Segment
  • Germany, Squamous Cell Carcinoma Antigen Test Volume and Diagnostics Sales Forecast By Market Segment
  • Germany, TDT Test Volume and Diagnostics Sales Forecast by Market Segment
  • Germany, Thymidine Kinase Test Volume and Diagnostics Sales Forecast by Market Segment
  • Germany, Thyroglobulin Test Volume and Diagnostics Sales Forecast by Market Segment
  • Germany, TPA Test Volume and Diagnostics Sales Forecast by Market Segment
  • Germany, Total Tumor Marker Sales By Major Supplier
  • Germany, AFP Testing Market Diagnostics Sales by Major Supplier Germany CA 15-3/27.29 Testing Market Diagnostics Sales by Major Supplier Germany CA 19-9 Testing Market Diagnostics Sales by Major Supplier
  • Germany, CA 125 Testing Market Diagnostics Sales by Major Supplier
  • Germany, CEA Testing Market Diagnostics Sales by Major Supplier
  • Germany, PSA Testing Market Diagnostics Sales by Major Supplier
  • Executive Summary Table: Italy, Total Tumor Marker Test Volume and Diagnostics Sales Forecast by Market Segment
  • Italy, Estimated Cancer Death Rates Per 100,000 Population
  • Italy, Laboratories Performing Tumor Marker Tests by Market Segment
  • Italy, Hospital Laboratories Performing Tumor Marker Tests by Bed Size
  • Italy, Commercial/Private Laboratories Performing Tumor Markers by Annual Test Volume
  • Italy, Total Tumor Marker Test Volume Forecast by Market Segment
  • Italy, All Market Segments Major Cancer Diagnostic Test Volume Forecast
  • Italy, Hospital Laboratories Major Tumor Marker Test Volume Forecast
  • Italy, Commercial/Private Laboratories Major Tumor Marker Test Volume Forecast
  • Italy, Total Tumor Marker Test Market Forecast by Market Segment
  • Italy, All Market Segments Major Tumor Marker Sales Forecast by Test
  • Italy, Hospital Laboratories Major Tumor Marker Forecast by Test
  • Italy, Commercial/Private Laboratories Major Tumor Marker Sales Forecast by Test
  • Italy, ACTH Test Volume and Diagnostics Sales Forecast by Market Segment
  • Italy, AFP Test Volume and Diagnostics Sales Forecast by Market Segment
  • Italy, Beta-2 Microglobulin Test Volume And Diagnostics Sales Forecast by Market Segment
  • Italy, CA 15-3/27.29 Test Volume and Diagnostics Sales Forecast by Market Segment
  • Italy, CA-19-9 Test Volume and Diagnostics Sales Forecast by Market Segment
  • Italy, CA 125 Test Volume and Diagnostics Sales Forecast by Market Segment
  • Italy, Calcitonin Test Volume and Diagnostics Sales Forecast by Market Segment
  • Italy, CEA Test Volume and Diagnostics Sales Forecast by Market Segment
  • Italy, Chromogranin Test Volume And Diagnostics Sales Forecast by Market Segment
  • Italy, Colon Specific Antigen Test Volume And Diagnostics Sales Forecast by Market Segment
  • Italy, Cytokeratins Test Volume and Diagnostics Sales Forecast by Market Segment
  • Italy, Estrogen Receptor Test Volume and Diagnostics Sales Forecast by Market Segment
  • Italy, Ferritin Test Volume and Diagnostics Sales Forecast by Market Segment
  • Italy, Gastrin Test Volume and Diagnostics Sales Forecast by Market Segment
  • Italy, HCG Test Volume and Diagnostics Sales Forecast by Market Segment
  • Italy, Insulin Test Volume and Diagnostics Sales Forecast by Market Segment
  • Italy, Lymphocyte Subtyping Test Volume And Diagnostics Sales Forecast by Market Segment
  • Italy, NSE Test Volume and Diagnostics Sales Forecast by Market Segment
  • Italy, Occult Blood Test Volume and Diagnostics Sales Forecast by Market Segment
  • Italy, Oncogenes Test Volume and Diagnostics Sales Forecast by Market Segment
  • Italy, Pancreatic Oncofetal Antigen Test Volume and Diagnostics Sales Forecast By Market Segment
  • Italy, PAP Smear Test Volume and Diagnostics Sales Forecast by Market Segment
  • Italy, Parathyroid Hormone Test Volume and Diagnostics Sales Forecast by Market Segment
  • Italy, Progesterone Receptor Test Volume and Diagnostics Sales Forecast by Market Segment
  • Italy, PAP Test Volume and Diagnostics Sales Forecast by Market Segment
  • Italy, PSA Test Volume and Diagnostics Sales Forecast by Market Segment
  • Italy, S-100 Test Volume and Diagnostics Sales Forecast by Market Segment
  • Italy, Serotonin Test Volume and Diagnostics Sales Forecast by Market Segment
  • Italy, Sialic Acid Test Volume and Diagnostics Sales Forecast by Market Segment
  • Italy, Squamous Cell Carcinoma Antigen Test Volume and Diagnostics Sales Forecast By Market Segment
  • Italy, TDT Test Volume and Diagnostics Sales Forecast by Market Segment
  • Italy, Thymidine Kinase Test Volume and Diagnostics Sales Forecast by Market Segment
  • Italy, Thyroglobulin Test Volume and Diagnostics Sales Forecast by Market Segment
  • Italy, TPA Test Volume and Diagnostics Sales Forecast by Market Segment
  • Italy, Total Tumor Markers Sales by Major Suppliers
  • Italy, AFP Testing Market Diagnostics Sales by Major Supplier
  • Italy, CEA Testing Market Diagnostics Sales by Major Supplier
  • Italy, PSA Testing Market Diagnostics Sales by Major Supplier
  • Executive Summary Table: Spain, Total Tumor Marker Test Volume and Sales Forecast by Market Segment
  • Spain, Estimated Cancer Death Rates Per 100,000 Population
  • Spain, Laboratories Performing Tumor Marker Tests by Market Segment
  • Spain, Hospital Laboratories Performing Tumor Marker Tests by Bed Size
  • Spain, Commercial/Private Laboratories Performing Tumor Markers by Annual Test Volume
  • Spain, Total Tumor Marker Test Volume Forecast by Market Segment
  • Spain, All Market Segment Major Cancer Diagnostic Test Volume Forecast
  • Spain, Hospital Laboratories Major Cancer Diagnostic Test Volume Forecast by Test
  • Spain, Commercial/Private Laboratories Major Tumor Marker Test Volume Forecast
  • Spain, Total Tumor Marker Sales Forecast by Market Segment
  • Spain, All Market Segments Major Tumor Marker Sales Forecast by Test
  • Spain, Hospital Laboratories Major Tumor Marker Sales Forecast by Test
  • Spain, Commercial/Private Laboratories Major Tumor Marker Sales Forecast by Test
  • Spain, AFP Test Volume and Diagnostics Sales Forecast by Market Segment
  • Spain, Beta-2 Microglobulin Test Volume and Diagnostics Sales Forecast by Market Segment
  • Spain, CA 15-3 Test Volume and Diagnostics Sales Forecast by Market Segment
  • Spain, CA 19-9 Test Volume and Diagnostics Sales Forecast by Market Segment
  • Spain, CA-125 Test Volume and Diagnostics Sales Forecast by Market Segment
  • Spain, Calcitonin Test Volume and Diagnostics Sales Forecast by Market Segment
  • Spain, CEA Test Volume and Diagnostics Sales Forecast by Market Segment
  • Spain, Colon-Specific Antigen Test Volume and Diagnostics Sales Forecast by Market Segment
  • Spain, Estrogen Receptor Test Volume and Diagnostics Sales Forecast by Market Segment
  • Spain, Ferritin Test Volume and Diagnostics Sales Forecast by Market Segment
  • Spain, Gastrin Test Volume and Diagnostics Sales Forecast by Market Segment
  • Spain, HCG Test Volume and Diagnostics Sales Forecast by Market Segment
  • Spain, Insulin Test Volume and Diagnostics Sales Forecast by Market Segment
  • Spain, Lymphocyte Subtyping Test Volume and Diagnostics Sales Forecast by Market Segment
  • Spain, NSE Test Volume and Diagnostics Sales Forecast by Market Segment
  • Spain, Occult Blood Test Volume and Diagnostics Sales Forecast by Market Segment
  • Spain, Oncogenes Test Volume and Diagnostics Sales Forecast by Market Segment
  • Spain, Pancreatic Oncofetal Antigen Test Volume and Diagnostics Sales Forecast by Market Segment
  • Spain, PAP Smear Test Volume and Diagnostics Sales Forecast by Market Segment
  • Spain, Parathyroid Hormone Test Volume And Diagnostics Sales Forecast by Market Segment
  • Spain, Progesterone Receptor Test Volume and Diagnostics Sales Forecast by Market Segment
  • Spain, PAP Test Volume and Diagnostics Sales Forecast by Market Segment
  • Spain, PSA Test Volume and Diagnostics Sales Forecast by Market Segment
  • Spain, S-100 Protein Test Volume And Diagnostics Sales Forecast by Market Segment
  • Spain, Serotonin Test Volume and Diagnostics Sales Forecast by Market Segment
  • Spain, Sialic Acid Test Volume and Diagnostics Sales Forecast by Market Segment
  • Spain, Squamous Cell Carcinoma Antigen Test Volume and Diagnostics Sales Forecast by Market Segment
  • Spain, TDT Test Volume and Diagnostics Sales Forecast by Market Segment
  • Spain, Thymidine Kinase Test Volume and Diagnostics Sales Forecast by Market Segment
  • Spain, Thyroglobulin Test Volume and Diagnostics Sales Forecast by Market Segment
  • Spain, TPA Test Volume and Diagnostics Sales Forecast by Market Segment
  • Spain, Total Tumor Marker Sales by Major Suppliers
  • Spain, AFP Testing Market Diagnostics Sales by Major Supplier
  • Spain, CA 15-3/27.29 Testing Market Diagnostics Sales by Major Supplier
  • Spain, 19-9 Testing Market Diagnostics Sales by Major Supplier
  • Spain, CA 125 Testing Market Diagnostics Sales by Major Supplier
  • Spain, CEA Testing Market Diagnostics Sales by Major Supplier
  • Spain, PSA Testing Market Diagnostics Sales by Major Supplier
  • Executive Summary Table: U.K., Total Tumor Marker Test Volume and Sales Forecast by Market Segment
  • U.K., Estimated Cancer Death Rates Per 100,000 Population
  • U.K., Laboratories Performing Tumor Marker Tests by Market Segment
  • U.K., Hospital Laboratories Performing Tumor Marker Tests by Bed Size
  • U.K., Commercial/Private Laboratories Performing Tumor Marker Tests by Annual Test Volume
  • U.K., Total Tumor Marker Testing Volume Forecast by Market Segment
  • U.K., All Market Segments Major Tumor Marker Test Volume Forecast
  • U.K., Hospital Laboratories Major Tumor Marker Test Volume Forecast by Test
  • U.K., Commercial/Private Laboratories Major Tumor Marker Test Volume Forecast
  • U.K., Total Tumor Marker Sales Forecast by Market Segment
  • U.K., All Market Segments Major Tumor Marker Sales Forecast by Test
  • U.K., Hospital Laboratories Major Tumor Marker Sales Forecast by Test
  • U.K., Commercial/Private Laboratories Major Tumor Marker Sales Forecast by Test
  • U.K., ACTH Test Volume and Diagnostics Sales Forecast by Market Segment
  • U.K., AFP Test Volume and Diagnostics Sales Forecast by Market Segment
  • U.K., Beta-2 Microglobulin Test Volume and Diagnostics Sales Forecast by Market Segment
  • U.K., CA 15-3/27.29 Test Volume and Diagnostics Sales Forecast by Market Segment
  • U.K., CA 19-9 Test Volume and Diagnostics Sales Forecast by Market Segment
  • U.K., CA-125 Test Volume and Diagnostics Sales Forecast by Market Segment
  • U.K., Calcitonin Test Volume and Diagnostics Sales Forecast by Market Segment
  • U.K., CEA Test Volume and Diagnostics Sales Forecast by Market Segment
  • U.K., Chromogranin Test Volume and Diagnostics Sales Forecast by Market Segment
  • U.K., Colon-Specific Antigen Test Volume And Diagnostics Sales by Market Segment
  • U.K., Cytokeratins Test Volume and Diagnostics Sales Forecast by Market Segment
  • U.K., Estrogen Receptor Test Volume and Diagnostics Sales Forecast by Market Segment
  • U.K., Ferritin Test Volume and Diagnostics Sales Forecast by Market Segment
  • U.K., Gastrin Test Volume and Diagnostics Sales Forecast by Market Segment
  • U.K., HCG Test Volume and Diagnostics Sales Forecast by Market Segment
  • U.K., Insulin Test Volume and Diagnostics Sales Forecast by Market Segment
  • U.K., Lymphocyte Subtyping Test Volume and Diagnostics Sales Forecast by Market Segment
  • U.K., NSE Test Volume and Diagnostics Sales Forecast by Market Segment
  • U.K., Occult Blood Test Volume and Diagnostics Sales Forecast by Market Segment
  • U.K., Oncogenes Test Volume and Diagnostics Sales Forecast by Market Segment
  • U.K., Pancreatic Oncofetal Antigen Test Volume and Diagnostics Sales Forecast by Market Segment
  • U.K., PAP Smear Test Volume and Diagnostics Sales Forecast by Market Segment
  • U.K., Parathyroid Hormone Test Volume and Diagnostics Sales Forecast by Market Segment
  • U.K., Progesterone Receptor Test Volume and Diagnostics Sales Forecast by Market Segment
  • U.K., PAP Test Volume and Diagnostics Sales Forecast by Market Segment
  • U.K., PSA Test Volume and Diagnostics Sales Forecast by Market Segment
  • U.K., S-100 Protein Test Volume and Diagnostics Sales Forecast by Market Segment
  • U.K., Serotonin Test Volume and Diagnostics Sales Forecast by Market Segment
  • U.K., Sialic Acid Test Volume and Diagnostics Sales Forecast by Market Segment
  • U.K., Squamous Cell Carcinoma Antigen Test Volume and Diagnostics Sales Forecast by Market Segment
  • U.K., TDT Test Volume and Diagnostics Sales Forecast by Market Segment
  • U.K., Thymidine Kinase Test Volume and Diagnostics Sales Forecast by Market Segment
  • U.K., Thyroglobulin Test Volume and Diagnostics Sales Forecast by Market Segment
  • U.K., TPA Test Volume and Diagnostics Sales Forecast by Market Segment
  • U.K., Total Tumor Marker Sales and Market Shares Forecast
  • U.K., CEA Testing Market Diagnostics Sales by Major Supplier
  • U.K., PSA Testing Market Diagnostics Sales by Major Supplier
Back to Top